Agnieszka Budny, Cezary Grochowski


Retinoblastoma is a tumor originating from the nuclear layer of the primary retinal photoreceptor cells, genetically determined. It develops due to a mutation in chromosome 13 in the q14 band. It is the most common, originally malignant intraocular change in childhood and accounts for 10-15% of cancer cases occurring in the first year of life [1]. Usually this cancer manifests itself as a leukocoria in a child under two years of age. In a congenital form, it can be multifocal, on both sides, and the risk of secondary cancers should also be taken into account. Diagnosis of retinoblastoma requires indirect ophthalmoscopy and research using imaging diagnostics techniques: ultrasonography (USG), magnetic resonance imaging (MRI) or computed tomography (CT). If left untreated, it leads to metastasis and death of the child. With the advancement of medicine, survival with modern treatment methods is> 95%. More and more often it is possible to save the mutant eye enucleation surgery. Immediate referral to an ophthalmologist's oncologist and proper management by an interdisciplinary team are necessary to optimize the visual effect and survival [2].


retinobastoma, tumour, child population

Full Text:



Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2012, National Cancer Institute. Bethesda, MD. Available at: (Accessed on March 30, 2016).

Dimaras H, Kimani K, Dimba EAO, Gronsdahl P, White A. et al: Retinoblastoma. Lancet 2012; 379: 1436–1446.

Ray A, Gombos DS, Vats TS: Retinoblastoma: An overview. Indian J Pediatr. 2012; 79: 916–921.

Perek D. Nowotwory lite. W: Pediatria. Kawalec W, Grenda R, Ziółkowska H, PZWL 2014 s.646

Young J.L., Smith M.A., Roffers S.D. i in. Retinoblastoma. W: Cancer Incidence and Survival among Children and Adolescents: United States SEER Program, 1975-1995, Ries L.A., Smith M.A., Gurney J.G. i in., National Cancer Institute, Bethesda, Maryland 1999. s. 73.

Knudson A. Mutation and cancer: statistical study of retinoblastoma. „Proc Natl Acad Sci U S A”. 68. 4, s. 820-823, 1971. PMID: 5279523.

Kaliki S, Shields CL, Rojanaporn D, et al.: High-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes. Ophthalmology 120 (5): 997-1003, 2013.]

Fletcher O, Easton D, Anderson K, et al.: Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst 96 (5): 357-63, 2004. [PUBMED Abstract]

Marees T, van Leeuwen FE, de Boer MR, et al.: Cancer mortality in long-term survivors of retinoblastoma. Eur J Cancer 45 (18): 3245-53, 2009.

Kleinerman RA, Tucker MA, Abramson DH, et al.: Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst 99 (1): 24-31, 2007.

Shinohara ET, DeWees T, Perkins SM: Subsequent malignancies and their effect on survival in patients with retinoblastoma. Pediatr Blood Cancer 61 (1): 116-9, 2014

de Jong MC, Kors WA, de Graaf P, et al.: Trilateral retinoblastoma: a systematic review and meta-analysis. Lancet Oncol 15 (10): 1157-67, 2014.

Truong B, Green AL, Friedrich P, et al.: Ethnic, Racial, and Socioeconomic Disparities in Retinoblastoma. JAMA Pediatr 169 (12): 1096-104, 2015.]

Khurana A, Eisenhut CA, Wan W, et al.: Comparison of the diagnostic value of MR imaging and ophthalmoscopy for the staging of retinoblastoma. Eur Radiol 23 (5): 1271-80, 2013.]

Richter S, Vandezande K, Chen N, et al.: Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet 72 (2): 253-69, 2003.

Chojniak MM, Chojniak R, Testa ML, et al.: Abnormal orbital growth in children submitted to enucleation for retinoblastoma treatment. J Pediatr Hematol Oncol 34 (3): e102-5, 2012.

Lambert MP, Shields C, Meadows AT: A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy. Pediatr Blood Cancer 50 (2): 223-6, 2008.

Batra A, Thakar A, Bakhshi S: Ototoxicity in retinoblastoma survivors treated with carboplatin based chemotherapy: A cross-sectional study of 116 patients. Pediatr Blood Cancer 62 (11): 2060, 2015.

Qaddoumi I, Bass JK, Wu J, et al.: Carboplatin-associated ototoxicity in children with retinoblastoma. J Clin Oncol 30 (10): 1034-41, 2012.

Jabbour P, Chalouhi N, Tjoumakaris S, Gonzalez LF, Dumont AS. et al: Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma. J Neurosurg Pediatrics 2012; 10: 175–181.

Sethi RV, Shih HA, Yeap BY, et al.: Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy. Cancer 120 (1): 126-33, 2014.

Shields CL, Shields JA, Cater J, Othmane I, Singh AD, Micaily B: Plaque radiotherapy for retinoblastoma—Long-term tumor control and treatment complications in 208

Krengli M. Hug EB, Adams JA et al. Proton radiation therapy for retinoblastoma: comparison of various intraocular tumor locations and beam arrangements. Int J Radiat Oncol Biol Phys 2005; 61: 583-593

Shields CL, Santos C, Diniz W, Gündüz K, Mercado G. et al: Thermotherapy for retinoblastoma. Arch Ophthalmol. 1999; 117: 885–893.



  • There are currently no refbacks.

Copyright (c) 2018 © The Author(s)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Journal of Education, Health and Sport formerly Journal of Health Sciences

Declaration on the original version.

Editors indicates that the main version of the magazine is to issue a "electronic".

The journal has had 5 points in Ministry of Science and Higher Education parametric evaluation. § 8. 2) and § 12. 1. 2) 22.02.2019.

1223 Journal of Education, Health and Sport eISSN 2391-8306 7

ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

Archives 2011 - 2014

PBN 2011 - 2014

POL-index 2011 - 2014

BASE 2011 - 2014

Indexed in Bases, Bazy indeksacyjne: ERIH Plus, Worldcat, PBN/POL-Index, ICI Journals Master List, Directory of Open Access Journals (DOAJ), ZBD, Ulrich's periodicals, Google Scholar, Polska Bibliografia Lekarska

US NLM = 101679844

101679844 - NLM Catalog Result - NCBI

Find a library that holds this journal:

Journal Language(s): English 

PBN Poland



Redaction, Publisher and Editorial Office

Instytut Kultury Fizycznej Uniwersytet Kazimierza Wielkiego w Bydgoszczy, Institute of Physical Education Kazimierz Wielki University in Bydgoszcz, Poland 85-091 Bydgoszcz ul. Sportowa 2 Copyright by Instytut Kultury Fizycznej UKW w Bydgoszczy  Open Access ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

The journal has been approved for inclusion in ERIH PLUS.

The ERIH PLUS listing of the journal is available at

SIC Science citation index (calculated on the basis of TCI and Page Rank) 0

Russian Impact factor 0.16

Indexed in Index Copernicus Journals Master List.,p24782242,3.html

ICV 2018 = 95.95 ICV 2017 = 91.30 ICV 2016 = 84.69 ICV 2015 = 93.34 ICV 2014 = 89.51 Standardized Value: 8.27 ICV 2013: 7.32 ICV 2012: 6.41 ICV 20115.48

The InfoBase Index IBI Factor for the year 2015 is 3.56 in InfoBase


Universal Impact Factor 1.78 for year 2012. (

Indexed in Polish Scholarly Bibliography (PBN) (PBN Polska Bibliografia Naukowa) (

is a portal of the Polish Ministry of Science and Higher Education, collecting information on publications of Polish scientists and on Polish and foreign scholarly journals. Polish Scholarly Bibliograhpy is a part of POL-on - System of Information on Higher Education. It is operated by the Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw.

Indexed in Russian Sciences Index Российский индекс научного цитирования (РИНЦ)

Indexed in Arianta Polish scientific and professional electronic journals Aneta Drabek i Arkadiusz Pulikowski